Tawfik Nehad M, Hegazy Mona A, Hassan Ehab A, Ramadan Yomna K, Nasr Aml S
Department of Internal Medicine, Cairo & El Fayoum Universities, Cairo, Egypt.
Blood Coagul Fibrinolysis. 2011 Dec;22(8):701-5. doi: 10.1097/MBC.0b013e32834c6c9c.
To evaluate the utility of the 4Ts clinical scoring system as a pretest probability method for detection of heparin-induced thrombocytopenia (HIT). Medical and surgical inpatients and outpatients at Kasr El Eini hospital. This single-centre series of 50 HIT testing referrals assessed combination of clinical score (thrombocytopenia, timing, thrombosis, other causes of thrombocytopenia not evident; 4T's), Heparin platelet factor 4 (H-PF4) rapid particle gel immunoassay (PaGIA) and 14C serotonin release assay (SRA) to develop a practical and well tolerated diagnostic strategy for HIT. Sixteen patients (32%) had a low 4T's score, 26 (52%) had an intermediate score and only eight (16%) had a high score. A positive H-PF4 by PaGIA was seen in seven patients (14%). As might be anticipated, the likelihood of obtaining a positive H-PF4 by PaGIA increased with an increasing clinical score, with positive H-PF4 by PaGIA results in low, intermediate and high scoring patients of 6.25, 7.7 and 50%, respectively. The positive predictive value of a positive PaGIA was 92%. The negative predictive value was 100%. Five patients (10%) in our cohort had a positive SRA. All patients with a positive SRA were included in the intermediate (two of 26 patients, 7.7%) or high (three of eight patients, 37.5%) score groups. The negative predictive value of a low 4T's score was 100%, effectively ruling out HIT. A low 4Ts score supports low probability of HIT based on the results of the PaGIA and SRA. Overall, the interrater reliability of the scoring system was fair.
评估4T临床评分系统作为检测肝素诱导的血小板减少症(HIT)的预检概率方法的效用。开罗大学医学院附属医院的内科和外科住院及门诊患者。这一包含50例HIT检测转诊病例的单中心系列研究评估了临床评分(血小板减少症、时间、血栓形成、血小板减少症的其他明显病因;4T)、肝素血小板因子4(H-PF4)快速颗粒凝胶免疫测定(PaGIA)和14C血清素释放试验(SRA)的组合,以制定一种实用且耐受性良好的HIT诊断策略。16例患者(32%)4T评分为低分,26例(52%)为中等评分,仅8例(16%)为高分。7例患者(14%)PaGIA检测H-PF4呈阳性。正如预期的那样,随着临床评分增加,PaGIA检测H-PF4呈阳性的可能性增加,低分、中等评分和高分患者中PaGIA检测H-PF4呈阳性的比例分别为6.25%、7.7%和50%。PaGIA检测呈阳性的阳性预测值为92%。阴性预测值为100%。我们队列中有5例患者(10%)SRA呈阳性。所有SRA呈阳性的患者都在中等评分组(26例患者中的2例,7.7%)或高评分组(8例患者中的3例,37.5%)。4T低分的阴性预测值为100%,有效排除了HIT。基于PaGIA和SRA的结果,4T低分提示HIT可能性低。总体而言,评分系统的评分者间信度一般。